Target Name: THEM4
NCBI ID: G117145
Review Report on THEM4 Target / Biomarker Content of Review Report on THEM4 Target / Biomarker
THEM4
Other Name(s): C-terminal modulator protein | thioesterase superfamily member 4 | acyl-CoA thioesterase THEM4 | CTMP | THEM4_HUMAN | Acyl-coenzyme A thioesterase THEM4 | carboxyl-terminal modulator protein | MGC29636 | Acyl-CoA thioesterase THEM4 | Carboxyl-terminal modulator protein | OTTHUMP00000015248 | Thioesterase superfamily member 4

C-terminal Modulator Protein: Role in Gene Expression and Disease

The C-terminal modulator protein (CMRP) is a protein that plays a crucial role in the regulation of gene expression. It is a transmembrane protein that is involved in the transcription complex, which is responsible for driving the transcription of DNA into RNA. CMRP is composed of multiple domains, including an N-terminal transmembrane domain, a catalytic domain, and a C-terminal domain. The C-terminal domain is the site of the protein's activity and is involved in the regulation of gene expression.

The C-terminal modulator protein is a protein that is expressed in most tissues and cells. It is involved in the regulation of gene expression and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. terminal modulator protein is also a drug target and has been identified as a potential therapeutic target in a number of diseases.

The C-terminal modulator protein is a transmembrane protein that is involved in the regulation of gene expression. It is composed of multiple domains, including an N-terminal transmembrane domain, a catalytic domain, and a C-terminal domain. domain is the site of the protein's activity and is involved in the regulation of gene expression.

The N-terminal transmembrane domain of CMRP is involved in the regulation of the activity of the protein. It is thought to play a role in the regulation of the levels of CMRP in the cytoplasm and is involved in the regulation of the stability of the protein.

The catalytic domain of CMRP is responsible for the protein's catalytic activity. It is thought to play a role in the regulation of the activity of the protein and is involved in the regulation of the levels of CMRP in the cytoplasm.

The C-terminal domain of CMRP is the site of the protein's activity and is involved in the regulation of gene expression. It is thought to play a role in the regulation of the levels of CMRP in the cytoplasm and is involved in the regulation of the stability of the protein.

The C-terminal modulator protein is a drug target that has been identified as a potential therapeutic target in a number of diseases. It is also a biomarker that can be used to diagnose and monitor a number of diseases.

The C-terminal modulator protein is a protein that is involved in the regulation of gene expression and has been implicated in a number of diseases. It is also a potential therapeutic target and a biomarker for a number of diseases. Further research is needed to fully understand the role of CMRP in disease and to develop effective treatments.

Protein Name: Thioesterase Superfamily Member 4

Functions: Has acyl-CoA thioesterase activity towards medium and long-chain (C14 to C18) fatty acyl-CoA substrates, and probably plays a role in mitochondrial fatty acid metabolism. Plays a role in the apoptotic process, possibly via its regulation of AKT1 activity. According to PubMed:11598301, inhibits AKT1 phosphorylation and activity. According to PubMed:17615157, enhances AKT1 activity by favoring its phosphorylation and translocation to plasma membrane

The "THEM4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about THEM4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

THEM5 | THEM6 | THEMIS | THEMIS2 | THG1L | Thioredoxin-disulfide reductase (TrxR) | THNSL1 | THNSL2 | THO complex | THOC1 | THOC2 | THOC3 | THOC5 | THOC6 | THOC7 | Thomsen-Friedenreich Antigen (CD176) | THOP1 | THORLNC | THPO | THRA | THRAP3 | THRB | Three amino acid loop extension transcription regulators | Threonine protease | THRIL | THRSP | THSD1 | THSD1P1 | THSD4 | THSD4-AS1 | THSD7A | THSD7B | THTPA | THUMPD1 | THUMPD2 | THUMPD3 | THUMPD3-AS1 | THY1 | Thymidine Kinase | THYN1 | Thyroid hormone receptor | Thyrostimulin | Thyrotropin | TIA1 | TIAF1 | TIAL1 | TIAM1 | TIAM1-AS1 | TIAM2 | TICAM1 | TICAM2 | TICAM2-AS1 | TICRR | Tie Receptor | TIE1 | TIFA | TIFAB | TIGAR | TIGD1 | TIGD2 | TIGD3 | TIGD4 | TIGD5 | TIGD6 | TIGD7 | TIGIT | TIM22 complex | TIM23 Complex | TIMD4 | TIMELESS | TIMM10 | TIMM10B | TIMM13 | TIMM17A | TIMM17B | TIMM21 | TIMM22 | TIMM23 | TIMM29 | TIMM44 | TIMM50 | TIMM8-TIMM13 complex | TIMM8A | TIMM8AP1 | TIMM8B | TIMM9 | TIMMDC1 | TIMP1 | TIMP2 | TIMP3 | TIMP4 | TINAG | TINAGL1 | TINCR | TINF2 | TIPARP | TIPARP-AS1 | TIPIN | TIPRL | TIRAP